Natural clusters of tuberous sclerosis complex (TSC)-associated neuropsychiatric disorders (TAND): new findings from the TOSCA TAND research project.

ASD Cluster analysis Factor analysis Natural TAND clusters Neuropsychiatric Registry TAND TOSCA Tuberous sclerosis complex

Journal

Journal of neurodevelopmental disorders
ISSN: 1866-1955
Titre abrégé: J Neurodev Disord
Pays: England
ID NLM: 101483832

Informations de publication

Date de publication:
01 09 2020
Historique:
received: 06 01 2020
accepted: 30 07 2020
entrez: 3 9 2020
pubmed: 3 9 2020
medline: 18 9 2021
Statut: epublish

Résumé

Tuberous sclerosis complex (TSC)-associated neuropsychiatric disorders (TAND) have unique, individual patterns that pose significant challenges for diagnosis, psycho-education, and intervention planning. A recent study suggested that it may be feasible to use TAND Checklist data and data-driven methods to generate natural TAND clusters. However, the study had a small sample size and data from only two countries. Here, we investigated the replicability of identifying natural TAND clusters from a larger and more diverse sample from the TOSCA study. As part of the TOSCA international TSC registry study, this embedded research project collected TAND Checklist data from individuals with TSC. Correlation coefficients were calculated for TAND variables to generate a correlation matrix. Hierarchical cluster and factor analysis methods were used for data reduction and identification of natural TAND clusters. A total of 85 individuals with TSC (female:male, 40:45) from 7 countries were enrolled. Cluster analysis grouped the TAND variables into 6 clusters: a scholastic cluster (reading, writing, spelling, mathematics, visuo-spatial difficulties, disorientation), a hyperactive/impulsive cluster (hyperactivity, impulsivity, self-injurious behavior), a mood/anxiety cluster (anxiety, depressed mood, sleep difficulties, shyness), a neuropsychological cluster (attention/concentration difficulties, memory, attention, dual/multi-tasking, executive skills deficits), a dysregulated behavior cluster (mood swings, aggressive outbursts, temper tantrums), and an autism spectrum disorder (ASD)-like cluster (delayed language, poor eye contact, repetitive behaviors, unusual use of language, inflexibility, difficulties associated with eating). The natural clusters mapped reasonably well onto the six-factor solution generated. Comparison between cluster and factor solutions from this study and the earlier feasibility study showed significant similarity, particularly in cluster solutions. Results from this TOSCA research project in an independent international data set showed that the combination of cluster analysis and factor analysis may be able to identify clinically meaningful natural TAND clusters. Findings were remarkably similar to those identified in the earlier feasibility study, supporting the potential robustness of these natural TAND clusters. Further steps should include examination of larger samples, investigation of internal consistency, and evaluation of the robustness of the proposed natural clusters.

Sections du résumé

BACKGROUND
Tuberous sclerosis complex (TSC)-associated neuropsychiatric disorders (TAND) have unique, individual patterns that pose significant challenges for diagnosis, psycho-education, and intervention planning. A recent study suggested that it may be feasible to use TAND Checklist data and data-driven methods to generate natural TAND clusters. However, the study had a small sample size and data from only two countries. Here, we investigated the replicability of identifying natural TAND clusters from a larger and more diverse sample from the TOSCA study.
METHODS
As part of the TOSCA international TSC registry study, this embedded research project collected TAND Checklist data from individuals with TSC. Correlation coefficients were calculated for TAND variables to generate a correlation matrix. Hierarchical cluster and factor analysis methods were used for data reduction and identification of natural TAND clusters.
RESULTS
A total of 85 individuals with TSC (female:male, 40:45) from 7 countries were enrolled. Cluster analysis grouped the TAND variables into 6 clusters: a scholastic cluster (reading, writing, spelling, mathematics, visuo-spatial difficulties, disorientation), a hyperactive/impulsive cluster (hyperactivity, impulsivity, self-injurious behavior), a mood/anxiety cluster (anxiety, depressed mood, sleep difficulties, shyness), a neuropsychological cluster (attention/concentration difficulties, memory, attention, dual/multi-tasking, executive skills deficits), a dysregulated behavior cluster (mood swings, aggressive outbursts, temper tantrums), and an autism spectrum disorder (ASD)-like cluster (delayed language, poor eye contact, repetitive behaviors, unusual use of language, inflexibility, difficulties associated with eating). The natural clusters mapped reasonably well onto the six-factor solution generated. Comparison between cluster and factor solutions from this study and the earlier feasibility study showed significant similarity, particularly in cluster solutions.
CONCLUSIONS
Results from this TOSCA research project in an independent international data set showed that the combination of cluster analysis and factor analysis may be able to identify clinically meaningful natural TAND clusters. Findings were remarkably similar to those identified in the earlier feasibility study, supporting the potential robustness of these natural TAND clusters. Further steps should include examination of larger samples, investigation of internal consistency, and evaluation of the robustness of the proposed natural clusters.

Identifiants

pubmed: 32873244
doi: 10.1186/s11689-020-09327-0
pii: 10.1186/s11689-020-09327-0
pmc: PMC7465404
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

24

Investigateurs

Nobuo Shinohara (N)
Shigeo Horie (S)
Masaya Kubota (M)
Jun Tohyama (J)
Katsumi Imai (K)
Mari Kaneda (M)
Hideo Kaneko (H)
Yasushi Uchida (Y)
Tomoko Kirino (T)
Shoichi Endo (S)
Yoshikazu Inoue (Y)
Katsuhisa Uruno (K)
Ayse Serdaroglu (A)
Zuhal Yapici (Z)
Banu Anlar (B)
Sakir Altunbasak (S)
Olga Lvova (O)
Oleg Valeryevich Belyaev (OV)
Oleg Agranovich (O)
Elena Vladislavovna Levitina (EV)
Yulia Vladimirovna Maksimova (YV)
Antonina Karas (A)
Yuwu Jiang (Y)
Liping Zou (L)
Kaifeng Xu (K)
Yushi Zhang (Y)
Guoming Luan (G)
Yuqin Zhang (Y)
Yi Wang (Y)
Meiling Jin (M)
Dingwei Ye (D)
Weiping Liao (W)
Liemin Zhou (L)
Jie Liu (J)
Jianxiang Liao (J)
Bo Yan (B)
Yanchun Deng (Y)
Li Jiang (L)
Zhisheng Liu (Z)
Shaoping Huang (S)
Hua Li (H)
Kijoong Kim (K)
Pei-Lung Chen (PL)
Hsiu-Fen Lee (HF)
Jeng-Dau Tsai (JD)
Ching-Shiang Chi (CS)
Chao-Ching Huang (CC)
Kate Riney (K)
Deborah Yates (D)
Patrick Kwan (P)
Surachai Likasitwattanakul (S)
Charcrin Nabangchang (C)
Lunliya Thampratankul Krisnachai Chomtho (LTK)
Kamornwan Katanyuwong (K)
Somjit Sriudomkajorn (S)
Jo Wilmshurst (J)
Reeval Segel (R)
Tal Gilboa (T)
Michal Tzadok (M)
Aviva Fattal-Valevski (A)
Panagiotis Papathanasopoulos (P)
Antigone Syrigou Papavasiliou (AS)
Stylianos Giannakodimos (S)
Stylianos Gatzonis (S)
Evangelos Pavlou (E)
Meropi Tzoufi (M)
A M H Vergeer (AMH)
Marc Dhooghe (M)
Hélène Verhelst (H)
Filip Roelens (F)
Marie Cecile Nassogne (MC)
Pierre Defresne (P)
Liesbeth De Waele (L)
Patricia Leroy (P)
Nathalie Demonceau (N)
Benjamin Legros (B)
Patrick Van Bogaert (P)
Berten Ceulemans (B)
Lina Dom (L)
Pierre Castelnau (P)
Anne De Saint Martin (AS)
Audrey Riquet (A)
Mathieu Milh (M)
Claude Cances (C)
Jean-Michel Pedespan (JM)
Dorothee Ville (D)
Agathe Roubertie (A)
Stéphane Auvin (S)
Patrick Berquin (P)
Christian Richelme (C)
Catherine Allaire (C)
Sophie Gueden (S)
Sylvie Nguyen The Tich (SNT)
Bertrand Godet (B)
Maria Luz Ruiz Falco Rojas (MLRF)
Jaume Campistol Planas (JC)
Antonio Martinez Bermejo (AM)
Patricia Smeyers Dura (PS)
Susana Roldan Aparicio (SR)
Maria Jesus Martinez Gonzalez (MJM)
Javier Lopez Pison (JL)
Manuel Oscar Blanco Barca (MOB)
Eduardo Lopez Laso (EL)
Olga Alonso Luengo (OA)
Francisco Javier Aguirre Rodriguez (FJA)
Ignacio Malaga Dieguez (IM)
Ana Camacho Salas (AC)
Itxaso Marti Carrera (IM)
Eduardo Martinez Salcedo (EM)
Maria Eugenia Yoldi Petri (MEY)
Ramon Cancho Candela (RC)
Ines da Conceicao Carrilho (I)
Jose Pedro Vieira (JP)
José Paulo da Silva Oliveira Monteiro (JP)
Miguel Jorge Santos de Oliveira Ferreira Leao (MJS)
Catarina Sofia Marceano Ribeiro Luis (CSMR)
Carla Pires Mendonca (CP)
Milda Endziniene (M)
Jurgis Strautmanis (J)
Inga Talvik (I)
Maria Paola Canevini (MP)
Antonio Gambardella (A)
Dario Pruna (D)
Salvatore Buono (S)
Elena Fontana (E)
Bernardo Dalla Bernardina (BD)
Carmen Burloiu (C)
Iuliu Stefan Bacos Cosma (ISB)
Mihaela Adela Vintan (MA)
Laura Popescu (L)
Karel Zitterbart (K)
Jaroslava Payerova (J)
Ladislav Bratsky (L)
Zuzana Zilinska (Z)
Ursula Gruber-Sedlmayr (U)
Matthias Baumann (M)
Edda Haberlandt (E)
Kevin Rostasy (K)
Ekaterina Pataraia (E)
Frances Elmslie (F)
Clare Ann Johnston (CA)
Pamela Crawford (P)
Peter Uldall (P)
Maria Dahlin (M)
Paul Uvebrant (P)
Olof Rask (O)
Marit Bjoernvold (M)
Eylert Brodtkorb (E)
Andreas Sloerdahl (A)
Ragnar Solhoff (R)
Martine Sofie Gilje Jaatun (MSG)
Marek Mandera (M)
Elzbieta Janina Radzikowska (EJ)
Mariusz Wysocki (M)
Michael Fischereder (M)
Gerhard Kurlemann (G)
Bernd Wilken (B)
Adelheid Wiemer-Kruel (A)
Klemens Budde (K)
Klaus Marquard (K)
Markus Knuf (M)
Andreas Hahn (A)
Hans Hartmann (H)
Andreas Merkenschlager (A)
Regina Trollmann (R)

Références

Curr Opin Psychiatry. 2015 Mar;28(2):113-20
pubmed: 25602245
Pediatr Neurol. 2018 Apr;81:38-44
pubmed: 29530301
Curr Med Res Opin. 2011 Aug;27(8):1571-83
pubmed: 21692602
Eur Child Adolesc Psychiatry. 2007 Feb;16(1):16-24
pubmed: 17268883
Lancet Neurol. 2015 Jul;14(7):733-45
pubmed: 26067126
Pediatr Neurol. 2015 Jan;52(1):25-35
pubmed: 25532776
Pediatr Neurol. 2015 Apr;52(4):435-41
pubmed: 25771998
Am J Med Genet C Semin Med Genet. 2018 Sep;178(3):309-320
pubmed: 30117265
Mol Brain. 2016 May 23;9(1):56
pubmed: 27216612
Orphanet J Rare Dis. 2014 Nov 26;9:182
pubmed: 25424195
N Engl J Med. 2006 Sep 28;355(13):1345-56
pubmed: 17005952
Pediatr Neurol. 2013 Oct;49(4):255-65
pubmed: 24053983
Eur Arch Psychiatry Clin Neurosci. 2017 Aug;267(5):455-463
pubmed: 27263037
Pediatr Neurol. 2015 Jan;52(1):16-24
pubmed: 25499093
Front Pharmacol. 2018 Aug 30;9:964
pubmed: 30214408
Neurotherapeutics. 2010 Jul;7(3):275-82
pubmed: 20643380
Handb Clin Neurol. 2008;87:129-51
pubmed: 18809023

Auteurs

Petrus J de Vries (PJ)

Division of Child and Adolescent Psychiatry, University of Cape Town, 46 Sawkins Road, Rondebosch, Cape Town, 7700, South Africa. petrus.devries@uct.ac.za.

Elena Belousova (E)

Research and Clinical Institute of Pediatrics, Pirogov Russian National Research Medical University, Moscow, Russian Federation.

Mirjana P Benedik (MP)

SPS Pediatrična Klinika, Ljubljana, Slovenia.

Tom Carter (T)

TSA Tuberous Sclerosis Association, Nottingham, UK.

Vincent Cottin (V)

Hôpital Louis Pradel, Claude Bernard University Lyon 1, Lyon, France.

Paolo Curatolo (P)

Tor Vergata University Hospital, Rome, Italy.

Lisa D'Amato (L)

Novartis Farma S.p.A., Origgio, Italy.

Guillaume Beure d'Augères (G)

Association Sclérose Tubéreuse de Bourneville, Gradignan, France.

José C Ferreira (JC)

Centro Hospitalar Lisboa Ocidental, Lisbon, Portugal.

Martha Feucht (M)

Universitätsklinik für Kinder-und Jugendheilkunde, Affiliated Partner of the ERN EpiCARE, Vienna, Austria.

Carla Fladrowski (C)

Associazione Sclerosi Tuberosa ONLUS, Milan, Italy.
European Tuberous Sclerosis Complex Association, In den Birken, Datteln, Germany.

Christoph Hertzberg (C)

Vivantes-Klinikum Neukölln, Berlin, Germany.

Sergiusz Jozwiak (S)

Department of Child Neurology, Warsaw Medical University, Warsaw, Poland.
Department of Neurology and Epileptology, The Children's Memorial Health Institute, Warsaw, Poland.

John A Lawson (JA)

The Tuberous Sclerosis Multidisciplinary Management Clinic, Sydney Children's Hospital, Randwick, NSW, Australia.

Alfons Macaya (A)

Hospital Universitari Vall d'Hebron, Barcelona, Spain.

Ruben Marques (R)

Novartis Farma S.p.A., Origgio, Italy.
Institute of Biomedicine (IBIOMED), University of Leon, León, Spain.

Rima Nabbout (R)

Department of Pediatric Neurology, Necker Enfants Malades Hospital, Paris Descartes University, Paris, France.

Finbar O'Callaghan (F)

Institute of Child Health, University College London, London, UK.

Jiong Qin (J)

Department of Pediatrics, Peking University People's Hospital (PKUPH), Beijing, China.

Valentin Sander (V)

Tallinn Children Hospital, Tallinn, Estonia.

Matthias Sauter (M)

Klinikverbund Kempten-Oberallgäu gGmbH, Kempten, Germany.

Seema Shah (S)

Novartis Healthcare Pvt. Ltd., Hyderabad, India.

Yukitoshi Takahashi (Y)

National Epilepsy Center, Shizuoka Institute of Epilepsy and Neurological Disorders, NHO, 886 Urushiyama Aoi-ku, Shizuoka, Japan.

Renaud Touraine (R)

Department of Genetics, CHU-Hôpital Nord, Saint Etienne, France.

Sotiris Youroukos (S)

St. Sophia Children's Hospital, Athens, Greece.

Bernard Zonnenberg (B)

University Medical Center, Utrecht, Netherlands.

J Chris Kingswood (JC)

Cardiology Clinical Academic Group, Molecular and Clinical Sciences Research Centre, St Georges University of London, London, SW17 0RE, UK.

Anna C Jansen (AC)

Pediatric Neurology Unit, Department of Pediatrics, UZ Brussel VUB, Brussels, Belgium.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH